An Examination of Demographic Involvement in Minimally Invasive Glaucoma Surgery and Cataract Surgery Clinical Trials: A Systematic Review. [PDF]
J Clin MedBackground: Glaucoma is the leading cause of global irreversible blindness, and it disproportionately affects people of African descent, in addition to having slightly higher prevalence rates in females.
Appelbaum J, Virk A, Patel D, Allison K.
europepmc +2 more sources
Phacoemulsification combined with trabecular meshwork-Schlemm canal-based minimally invasive glaucoma surgery in primary angle-closure glaucoma: a systematic review and meta-analysis. [PDF]
BMC OphthalmolTo summarize the efficacy and safety of the phacoemulsification with intraocular lens implantation (PEI) ± goniosynechialysis (GSL) + trabecular meshwork-Schlemm canal (TM-SC)-based minimally invasive glaucoma surgery (MIGS) in primary angle-closure ...
Fang Z, Song Y, Jin L, Han Y, Zhang X.
europepmc +2 more sources
Minimally invasive glaucoma surgery: comparison of Hydrus microstent with iStent <i>inject</i> in primary open-angle glaucoma. [PDF]
BMJ Open OphthalmolBackground To evaluate and compare the efficacy of a single Hydrus and double iStent inject both combined with cataract surgery for the treatment of primary open-angle glaucoma (POAG).
Komzak K, Allen PL, Toh T.
europepmc +2 more sources
Corneal endothelial safety profile in minimally invasive glaucoma surgery. [PDF]
J Cataract Refract Surg, 2023 Compared with cataract surgery alone, the addition of a MIGS device (iStent inject, Hydrus, CyPass) showed different corneal endothelial safety profiles in published pivotal trials.
Ahmed IIK +3 more
europepmc +2 more sources
Impact of minimally invasive glaucoma surgery on the ocular surface and quality of life in patients with glaucoma [PDF]
Therapeutic Advances in Ophthalmology, 2023 Background: Minimally invasive glaucoma procedures are emerging as clinically effective and safe glaucoma management approaches; however, evidence regarding quality-of-life outcomes is limited.
Lee Jones +3 more
doaj +2 more sources
The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review. [PDF]
Int J Environ Res Public Health, 2023 Recently, the quest for novel glaucoma surgical techniques and devices has been underway. Trabeculectomy remains the gold standard, but it requires the implantation of glaucoma drainage devices and frequent follow-ups, and it also carries a high risk of ...
Saeed E +4 more
europepmc +2 more sources
Performance and Safety of reused Kahook Dual Blade for combined cataract and minimally invasive glaucoma surgery in open angle-glaucoma. [PDF]
Indian J OphthalmolPurpose: To evaluate the performance and safety of reusing the Kahook Dual Blade (KDB) in patients with mild to moderate primary open-angle glaucoma and to assess its impact on clinical outcomes.
Sethi S, Dhir P.
europepmc +2 more sources
Comparison of the Intraocular Pressure-Lowering Effect of Minimally Invasive Glaucoma Surgery (MIGS) iStent Inject W and Hydrus-The 12-Month Real-Life Data. [PDF]
Diagnostics (Basel)Background/Objectives: To compare the efficacy and safety of Hydrus® Microstent and iStent inject® W implants, in combination with phacoemulsification, for lowering intraocular pressure (IOP) in patients with glaucoma in a real-world clinical setting ...
Weich C +5 more
europepmc +2 more sources
Minimally Invasive Glaucoma Surgery: Safety of Individual Devices. [PDF]
J Clin Med, 2022 Primary open-angle glaucoma progression in those already on maximal medical therapy has traditionally been treated with trabeculectomy, a surgical procedure that carries a high degree of morbidity. In the last few decades, significant advances have been made in the field of minimally invasive glaucoma surgery (MIGS) devices, which aim to defer or ...
Rowson AC, Hogarty DT, Maher D, Liu L.
europepmc +3 more sources
Clinical and Visual Field Outcomes Following Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery [PDF]
Clinical Ophthalmology, 2022 Marcus L Turner,1 Abu M Taha,1 Sean Yonamine,1 Yinxi Yu,2 Murtaza Saifee,1 Mike Yang,3 Gui-Shuang Ying,2 Ying Han,1 Julius T Oatts1 1Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA; 2Department of ...
Turner ML +8 more
doaj +2 more sources